Cited by 113Gut microbiota and healthAlzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms

A Review of the Brain-Gut-Microbiome Axis and the Potential Role of Microbiota in Alzheimer’s Disease

Sun, Miao, Ma, Kai, Wen, Jie, Wang, Guangxian, Zhang, Changliang, Li, Qi, Bao, Xiaofeng, Wang, Hui·2020·Journal of Alzheimer’s Disease

Abstract

Alzheimer’s disease (AD) is a neurodegenerative process characterized by loss of neurons in the hippocampus and cerebral cortex, leading to progressive cognitive decline. Pathologically, the hallmark of AD is accumulation of “senile” plaques composed of amyloid-β (Aβ) protein surrounding neurons in affected regions. Despite extensive research into AD pathogenesis and therapeutic targets, there remains no breakthroughs in its management. In recent years, there has been a spark of interest in the connection between the brain and gastrointestinal tract, referred to as the brain-gut axis, and its potential implications for both metabolic and neurologic disease. Moreover, the gastrointestinal flora, referred to as the microbiome, appears to exert significant influence over the brain-gut axis. With the need for expanded horizons in understanding and treating AD, many have turned to the brain-gut-microbiome axis for answers. Here we provide a review of the brain-gut-microbiome axis and discuss the evidence supporting alterations of the axis in the pathogenesis of AD. Specifically, we highlight the role for the microbiome in disruption of Aβ metabolism/clearance, increased permeability of the blood-brain barrier and modulation of the neuroinflammatory response, and inhibition of hippocampal neurogenesis. The majority of the above described findings are the result of excellent, albeit basic and pre-clinical studies. Therefore, we conclude with a brief description of documented clinical support for brain-gut-microbiome axis alteration in AD, including potential microbiome-based therapeutics for AD. Collectively, these findings suggest that the brain-gut-microbiome axis may be a “lost link” in understanding and treating AD and call for future work.

Integrity signals

Registry

Crossref · 10.3233/jad-190872

Cites

135 of 135 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Carabotti M, 2015, Ann Gastroenterol, 28, 203

Cited by

Sorted by citations

Authors
Sun, M., Ma, K., Wen, J., Wang, G., Zhang, C., Li, Q., Bao, X., & Wang, H.
Affiliations
  • Nantong University (CN)
  • Probiotics Australia, Ormeau, QLD, Australia
  • Beijing Allwegene Health, Beijing, China
  • Jiangsu Biodep Biotechnology, Jiangyin, Jiangsu, China
Corresponding author
  • Bao, Xiaofeng
  • Wang, Hui
Venue
Journal of Alzheimer’s Disease
Published
2019-12-26
Volume
73
Issue
3
Pages
849-865
ISSN
  • 1387-2877 (ISSN-L)
  • 1875-8908
OpenAlex
W2998207892
Cited by
113
References
135
Citations by year
2026: 12 · 2025: 14 · 2024: 20 · 2023: 15 · 2022: 18 · 2021: 16 · 2020: 17
FWCI
1.14
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Alzheimer s Disease (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
Alzheimer's disease, gut-brain axis
MeSH terms
Gastrointestinal Microbiome, Alzheimer Disease, Brain, Humans, Amyloid beta-Peptides, Gastrointestinal Tract, Plaque, Amyloid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review